UnitedHealth Group Incorporated (NYSE:UNH) Stake Lowered by Simplify Asset Management Inc.

Simplify Asset Management Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 40.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,057 shares of the healthcare conglomerate's stock after selling 8,315 shares during the period. UnitedHealth Group accounts for 0.3% of Simplify Asset Management Inc.'s investment portfolio, making the stock its 21st biggest holding. Simplify Asset Management Inc.'s holdings in UnitedHealth Group were worth $6,099,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Mosley Wealth Management lifted its stake in shares of UnitedHealth Group by 9.5% during the 4th quarter. Mosley Wealth Management now owns 1,400 shares of the healthcare conglomerate's stock valued at $753,000 after buying an additional 121 shares in the last quarter. Focused Investors LLC boosted its position in UnitedHealth Group by 4.1% during the fourth quarter. Focused Investors LLC now owns 426,600 shares of the healthcare conglomerate's stock valued at $215,800,000 after buying an additional 16,950 shares during the period. Guardian Partners Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $9,951,000. Fortis Capital Management LLC increased its stake in shares of UnitedHealth Group by 6.3% in the fourth quarter. Fortis Capital Management LLC now owns 9,480 shares of the healthcare conglomerate's stock worth $4,796,000 after buying an additional 560 shares during the period. Finally, KLP Kapitalforvaltning AS bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $157,543,000. 87.86% of the stock is currently owned by institutional investors.

Remove Ads

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on UNH shares. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial dropped their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. KeyCorp restated an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Trading Down 0.6 %

Shares of UnitedHealth Group stock traded down $2.92 on Tuesday, reaching $513.58. The company had a trading volume of 3,006,004 shares, compared to its average volume of 4,898,654. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market cap of $469.78 billion, a PE ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The firm's 50 day moving average price is $509.71 and its two-hundred day moving average price is $546.15.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. UnitedHealth Group's payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.